In adults with overweight or obesity and CKD without diabetes, semaglutide produced a marked reduction in albuminuria with stable eGFR and no renal safety signal [19], addressing a population historically underrepresented in GLP-1 receptor agonist trials
JV: Methodology, Supervision, Validation, Writing review and editing, Formal Analysis
Clinical Update 7/31/2019 Fresh vs
With their unique ability to regulate blood sugar and support weight loss, they offer new hope for millions
Choosing the right medication depends on your biology and goals
Even patients whose symptoms eventually improved may still have a claim, since lawsuits often cover medical costs, lost wages, and pain and suffering